Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
68 participants
OBSERVATIONAL
2007-12-31
2010-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We are interested in finding out whether these individual differences are genetic, that is caused by differences in our genes. Humans have about 1000 genes for odorant receptors. These are the molecules that bind and detect odor molecules in our nose and allow us to respond to so many different odors. It has been shown that some of these genes exist in two forms: a functional one and one that has been mutated and is therefore no longer functional.
We think that people who do not respond to a specific odor may carry the non-functional form of the gene for the receptor that detects the odor molecule. To test this idea we want to find people who respond strongly to a specific smell, and compare their odorant receptor genes with those of people who respond weakly to the odor.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dietary Plant Hormone and Mental Health
NCT05276479
Glucocorticoid Effects on Cellular Cytokine Release
NCT00001415
Examining Cortisol and Alpha Amylase in a Healthy Sample of Youth and Adults
NCT02490280
Estrogen Deficiency and Cardiovascular Disease in Premenopausal Women
NCT00572858
Correlation Between Changes in Sex Hormone Levels and Stress Urinary Incontinence in Women
NCT06109623
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
When the subject ovulates and is available for a visit she will come to the Rockefeller University Hospital within one day of detecting an LH surge for the first of four Test Sessions.
The four Test Sessions are identical with the exception that the subject is exposed to a different odor stimulus.
We will be measuring:
1. skin temperature
2. sweating, as measured by skin conductance
3. salivary cortisol levels.
4. mood
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Only subjects whose threshold to either vanillin or isovaleric acid is in the 90th percentile of the population tested in LVO-0539-0507 and who do not report any clinical conditions that may disturb their sense of smell will be enrolled in the study.
Exclusion Criteria
* Pregnancy
* Allergies to odors or fragrances
* History of nasal illness
* Irregular menstrual periods
* History of medical conditions that reduced or abolished sense of smell, such as: head injury, cancer therapy, radiation to the head and neck, or alcoholism.
18 Years
35 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rockefeller University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leslie Vosshall, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
The Rockefeller University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Rockefeller University Hospital
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LVO-0619
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.